Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Middle East Pharmaceutical Industries Company
SAR128
352
+SAR2
+1.59%
Sunday 12:18
1D
1W
1M
3M
1Y
5Y
Statistics
Day High
129
Day Low
127
52W High
197.6
52W Low
90.2
Volume
106,808
Avg. Volume
121,527
Mkt Cap
-
P/E Ratio
-
Dividend Yield
0.59%
Dividend
0.75
Upcoming
2
SEP
Dividend Ex
15
SEP
Dividend Payment
2
SEP 25
Dividend Ex
Estimated
15
SEP 25
Dividend Payment
Estimated
2
SEP 26
Dividend Ex
Estimated
15
SEP 26
Dividend Payment
Estimated
Dividends
0.59
%
Dividend Yield
Sep 24
SAR0.75
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
5
Aug
Confirmed
Q1 2024
Q2 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 4016.SR. It's not an investment recommendation.
Alphabet
71293
GOOGL
Apple
62564
AAPL
Microsoft
58315
MSFT
Amazon
53730
AMZN
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Saudi Pharmaceutical Indust. & Med. Appliances
2070.SR
Mkt Cap
2.85B
Tabuk Pharmaceutical Manufacturing Co. is a direct competitor, focusing on the development, manufacturing, and marketing of pharmaceuticals in the Middle East.
Dallah Healthcare Company
4004.SR
Mkt Cap
12.22B
Aldawaa Medical Services Company operates a chain of pharmacies across Saudi Arabia, competing in the pharmaceutical retail sector with Middle East Pharmaceutical Industries Company.
Al Mouwasat Medical Services Company
4002.SR
Mkt Cap
21.1B
Al Hammadi Company for Development and Investment operates hospitals and has interests in pharmaceuticals, competing in the healthcare and pharmaceutical sectors.
About
Show more...
CEO
ISIN
SA160G51UO10
Listings
SR
SA
4016.SR
Add to Watchlist